СОЛЮР Фармасьютикал Групп

СОЛЮР Фармасьютикал Групп

Menu
  • Home
  • About us
      • Our services
          • Pre-clinical study management
          • Сlinical study management
          • Generic bioequivalence study management
          • State Marketing Authorization
      • Cooperation
  • Contacts
  • Русский
  • English (UK)

Solyur Pharmaceuticals Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Welcome to our company!

 

 

Solyur Pharmaceuticals Group

Dear visitors!

I – Kiseleva Elena Vladimirovna - am the chief executive officer «SOLYUR Pharmaceuticals Group». Let me welcome you at our site. We hope this information will be useful for you.

Read more

Our advantages

1

Wide range of services

We offer full range of services in both management of the study and management of the authorization process and this saves time and helps to avoid material losses which occur due to the late introduction to the market.

2

Creativity

Our experience and complex approach to completing the tasks guarantee total control, evaluation and support of the project! We may design a strategy for pre-clinical or clinical studies and also for introducing the drug product to the market.

3

Customer-oriented approach

We always try to facilitate development of our Partners and we try hard to please current clients and find new ones! We always offer special terms to our regular customers.

4

Quality

We work for those who know the price of reputation and always consider quality! Especially for you, we gathered a control group that daily examine the documentation for compliance with the regulatory standards.

Our services

Pre-clinical study management

Pre-clinical trial of a medical drug is performed with the help of scientific evaluation methods in order to prove safety, quality and efficacy of the medicinal drug (Art. 11 of Federal law №61-FZ dated April, 2010 « On Medicine Circulation»). Pre-clinical trial of the medical drug is performed according to the rules of Good Laboratory Practice approved by the authorized federal government agency.

Read more

Сlinical study management (Phases I-IV)

Clinical study – is a study involving a human as the test subject for discovery or confirmation of clinical and/or pharmacological effects of the studied products and/or for detection of adverse drug reaction and/or for analyzing their absorption, distribution, metabolism in order to evaluate their safety and/or efficacy.

Read more

Generic bioequivalence study management

  • Biosimilar drug product— pharmaceutically equivalent and pharmaceutically alternative products with relatively similar bioavailability when compared in fair experimental conditions.
Read more

State Marketing Authorization

According to Part 1. art. 13 of Federal Law of the Russian Federation № 61-FZ , dated April 12, 2010  «On Medicine Circulation»  drug substances are put into civil commerce on the territory of the Russian Federation if they are licensed by an appropriate authorized federal executive agency.

Read more
  • About the company

    At the moment «SOLYUR Pharmaceuticals Group» consists of more than 40 high-quality specialists, who are professionals in their fields.

    Read more

Statistics

The number of partners

 

Completed projects

 

Current projects

 

Contacts

St. Trofimova, h. 14\1, floor 2, Moscow, Russia, 115432

E-mail: info@solyur.ru

Information

  • Cooperation

Our services

  • Pre-clinical study management
  • Сlinical study management (Phases I-IV)
  • Generic bioequivalence study management
  • State Marketing Authorization

Solyur-eng

  • Home
  • About us
  • Contacts
СОЛЮР Фармасьютикал Групп © 2023